Biologic Videos

31. Jubilant HollisterStier Capabilities Update March 2026: Fill/Finish 3/10/2026

    Reliable sterile manufacturing requires tailored support and consistent execution. Collaboration and strong quality systems help teams advance complex injectable products with confidence.

32. Argonaut Capabilities Update March 2026: Fill/Finish 3/10/2026

    Aseptic, isolator‑based fill‑finish spans multiple formats and batch sizes, supported by onsite analytics that cut hand‑offs and streamline testing. Learn how this setup boosts efficiency.

33. Fujifilm Biotechnologies Capabilities Update March 2026: Large Molecule 3/10/2026

    An overview of manufacturing strategies and scaling options shows how aligned systems, smart planning, and flexible models support biologics from early development to commercialization.

34. ProBio Capabilities Update March 2026: Large Molecule 3/10/2026

    A new Center of Excellence expands capacity for genetic‑medicine programs with upgraded facilities, streamlined workflows, and early‑stage services that support readiness for PD and IND milestones.

35. Boehringer Ingelheim Capabilities Update March 2026: Large Molecule 3/10/2026

    Integrated culture and fermentation systems streamline development, improve scalability, and strengthen continuity throughout the lifecycle of complex biopharmaceutical programs.

36. LNP And Liposomal Center Of Excellence 3/10/2026

    A connected development pathway supports smoother scale-up and greater consistency for LNP-based therapeutics. Explore how integrated expertise across key stages helps teams accelerate progress.

37. Strategies For Robust Process Characterization And Validation To Accelerate Biologics Manufacturing 3/8/2026

    Uncover how data-driven process design, effective technology transfer, and robust process characterization can accelerate validation readiness and help move biologics from development to commercial success faster.

38. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

    Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

39. Accelerator™ Drug Development 360° CDMO And CRO Solutions 3/4/2026

    Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.

40. Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right 3/3/2026

    This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.